Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
+1.73% | +0.97% |
Capitalization | 63.66B 54.62B 50.89B 47.35B 87.36B 5,483B 97.54B 615B 232B 2,571B 239B 234B 9,449B | P/E ratio 2018 |
-8.76x | P/E ratio 2019 | -11.9x |
---|---|---|---|---|---|
Enterprise value | 80.96B 69.47B 64.72B 60.22B 111B 6,973B 124B 782B 295B 3,269B 304B 297B 12,017B | EV / Sales 2018 |
4.24x | EV / Sales 2019 | 4.98x |
Free-Float |
99.9% | Yield 2018 |
2.15% | Yield 2019 | 1.55% |
More valuation ratios
* Estimated data
More news
More press releases
More news
Manager | Title | Age | Since |
---|---|---|---|
Alex Thurman
DFI | Director of Finance/CFO | 55 | 2016-11-30 |
Robert Michael
PSD | President | 54 | 2020-05-07 |
Director | Title | Age | Since |
---|---|---|---|
Robert Michael
BRD | Director/Board Member | 54 | 2020-05-07 |
Scott Reents
BRD | Director/Board Member | - | 2020-05-07 |
Ryan Quigley
BRD | Director/Board Member | - | 2020-05-07 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-.--% | +1.73% | - | - | 63.66B | ||
+1.34% | -2.69% | -9.09% | +139.83% | 693B | ||
+0.44% | +4.33% | +5.33% | -6.04% | 394B | ||
-1.12% | -1.66% | +10.59% | +26.54% | 334B | ||
-2.22% | -5.55% | -53.26% | -1.90% | 287B | ||
+0.58% | +0.66% | -7.15% | -21.43% | 259B | ||
-1.12% | -4.09% | -2.94% | +12.40% | 223B | ||
-0.17% | -1.49% | -15.11% | -7.23% | 215B | ||
-1.91% | -4.08% | -35.65% | -13.41% | 201B | ||
-1.17% | -0.17% | -10.94% | +20.88% | 158B | ||
Average | -0.46% | -1.40% | -13.14% | +16.63% | 282.86B | |
Weighted average by Cap. | -0.40% | -1.59% | -11.07% | +35.84% |
2018 | 2019 | |
---|---|---|
Net sales | 15.79B 13.55B 12.62B 11.74B 21.67B 1,360B 24.19B 152B 57.56B 637B 59.22B 57.99B 2,343B | 16.09B 13.8B 12.86B 11.97B 22.08B 1,386B 24.65B 155B 58.66B 650B 60.35B 59.1B 2,388B |
Net income | -5.1B -4.37B -4.07B -3.79B -6.99B -439B -7.81B -49.22B -18.58B -206B -19.12B -18.72B -756B | -5.27B -4.52B -4.21B -3.92B -7.23B -454B -8.08B -50.91B -19.22B -213B -19.77B -19.36B -782B |
Net Debt | 21.89B 18.78B 17.5B 16.28B 30.04B 1,885B 33.54B 211B 79.81B 884B 82.11B 80.41B 3,249B | 17.3B 14.85B 13.83B 12.87B 23.75B 1,490B 26.52B 167B 63.09B 699B 64.91B 63.56B 2,568B |
More financial data
* Estimated data
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Equities
- AGN Stock
Select your edition
All financial news and data tailored to specific country editions